Harvard Bioscience Inc (HBIO)
3.82
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
3.82
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Cash from Investing (Quarterly): -1.061M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.061M |
| September 30, 2023 | -0.401M |
| June 30, 2023 | -0.625M |
| March 31, 2023 | 0.288M |
| December 31, 2022 | -0.235M |
| September 30, 2022 | -0.442M |
| June 30, 2022 | -0.442M |
| March 31, 2022 | -0.471M |
| December 31, 2021 | -0.358M |
| September 30, 2021 | -0.48M |
| June 30, 2021 | -0.206M |
| March 31, 2021 | -0.301M |
| December 31, 2020 | -0.314M |
| September 30, 2020 | -0.564M |
| June 30, 2020 | -0.283M |
| March 31, 2020 | -0.241M |
| December 31, 2019 | -0.456M |
| September 30, 2019 | -0.361M |
| June 30, 2019 | 0.74M |
| March 31, 2019 | -0.152M |
| December 31, 2018 | -0.627M |
| September 30, 2018 | -0.257M |
| June 30, 2018 | -0.723M |
| March 31, 2018 | -52.19M |
| December 31, 2017 | -0.201M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.24M |
| June 30, 2017 | -0.248M |
| March 31, 2017 | -0.228M |
| December 31, 2016 | 0.892M |
| September 30, 2016 | -0.542M |
| June 30, 2016 | -0.207M |
| March 31, 2016 | -0.205M |
| December 31, 2015 | -0.68M |
| September 30, 2015 | -0.667M |
| June 30, 2015 | -0.581M |
| March 31, 2015 | -5.589M |
| December 31, 2014 | -12.37M |
| September 30, 2014 | -0.482M |
| June 30, 2014 | -0.497M |
| March 31, 2014 | -0.169M |
| December 31, 2013 | -0.458M |
| September 30, 2013 | 1.268M |
| June 30, 2013 | -0.285M |
| March 31, 2013 | -0.354M |
| December 31, 2012 | -0.698M |
| September 30, 2012 | -0.508M |
| June 30, 2012 | -0.798M |
| March 31, 2012 | -2.672M |
| December 31, 2011 | -0.748M |
| September 30, 2011 | -5.462M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.061M
Minimum
Dec 2023
0.74M
Maximum
Jun 2019
-0.327M
Average
-0.361M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -36.80M |
| Azenta Inc | 98.40M |
| Bionano Genomics Inc | -55.37M |
| Akoya Biosciences Inc | -0.594M |
| Singular Genomics Systems Inc | 0.651M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.303M |
| Cash from Financing (Quarterly) | -4.116M |
| Free Cash Flow | 11.72M |
| Free Cash Flow Per Share (Quarterly) | 0.076 |
| Free Cash Flow to Equity (Quarterly) | 5.422M |
| Free Cash Flow to Firm (Quarterly) | 4.551M |
| Free Cash Flow Yield | 7.20% |